Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a large-cap US stock, returning 11,890.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,890.16% |
Hims Hers Health (HIMS) | 122.3% |
AngloGold Ashanti (AU) | 100.61% |
Robinhood Markets (HOOD) | 86.09% |
Gold Fields Ltd ADR (GFI) | 83.47% |
Banco Santander SA ADR (SAN) | 79.76% |
NRG Energy (NRG) | 78.43% |
Palantir Technologies Inc Class A Common Stock (PLTR) | 74.76% |
Xpeng (XPEV) | 69.66% |
Carvana (CVNA) | 69.46% |
Bancolombia SA ADR (CIB) | 67.99% |
Banco Bradesco SA ADR (BBD) | 66.38% |
Kinross Gold (KGC) | 66.24% |
Deutsche Bank (DB) | 65.86% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 64.88% |
Xp (XP) | 64.57% |
Korea Electric Power Corp ADR (KEP) | 61.61% |
Elbit Systems (ESLT) | 60.91% |
Wheaton Precious Metals (WPM) | 60.84% |
Zscaler (ZS) | 60.3% |
Lloyds Banking Group PLC ADR (LYG) | 60.21% |
Sea (SE) | 57.59% |
United States Steel (X) | 57.55% |
Howmet Aerospace (HWM) | 56.85% |
Duolingo (DUOL) | 56.85% |
Large-cap stocks are treated as having a market cap of $10B+.
